Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase 1 (Cdk1), formerly called Cdc2 (or p34(Cdc2)), interacts with cyclin B1 to form an active heterodimer. The activity of Cdk1 is subjected to a complex spatiotemporary regulation, required to guarantee its scheduled contribution to the mitotic prophase and metaphase. Moreover, the activation of Cdk1 may be required for apoptosis induction in some particular pathways of cell killing. This applies to several clinically important settings, for instance to paclitaxel-induced killing of breast cancer cells, in which the ErbB2 receptor kinase can mediate apoptosis inhibition through inactivation of Cdk1. The activation of Cdk1 participates also in HIV-1-induced apoptosis, upstream of the p53-dependent mitochondrial permeabilization step. An unscheduled Cdk1 activation may contribute to neuronal apoptosis occurring in neurodegenerative diseases. Finally, the premature activation of Cdk1 can lead to mitotic catastrophe, for instance after irradiation-induced DNA damage. Thus, a cell type-specific modulation of Cdk1 might be taken advantage of for the therapeutic correction of pathogenic imbalances in apoptosis control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the primary alterations that drive catastrophic mitoses can originate in other phases of the cell cycles, including the S phase (e.g., a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [979]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“As shown in a phase II clinical trial, such cancers become responsive to taxol in vivo when taxol is combined with Herceptin (Trastuzumab), a humanized monoclonal anti-ErbB2 antibody.(24) In HL60 myelomonocytic leukemia cells, the taxolinduced Cdk1 activation is not affected by Bcl-2 nor is it inhibited by the pan-cas…”
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Self-citationMitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Organelle-specific initiation of cell death pathways
Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,456
Self-citationYamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., & Landau, N. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6705-6711.1995 · Cited by 904
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Freeman, R. S., Estus, S., & Johnson, E. M. (1994) · Neuron · doi:10.1016/0896-6273(94)90276-3 · Cited by 573
Premature p34 cdc2 Activation Required for Apoptosis
Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W., & Greenberg, A. H. (1994) · Science · doi:10.1126/science.8108732 · Cited by 557
Graves, P. R., Yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M., & Piwnica-Worms, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5600 · Cited by 544
Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 462
A unified view of the DNA-damage checkpoint
Melo, J., & Toczyski, D. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00312-5 · Cited by 457
Jacotot, E., Ravagnan, L., Loeffler, M., Ferri, K. F., Vieira, H. L. A., Zamzami, N., Costantini, P., Druillennec, S., Hoebeke, J., Briand, J. P., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.33 · Cited by 450
Self-citationVincent, I., Jicha, G., Rosado, M., & Dickson, D. W. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03588.1997 · Cited by 444
Chemotherapy: targeting the mitochondrial cell death pathway
Debatin, K.-M., Poncet, D., & Kroemer, G. (2002) · Oncogene · doi:10.1038/sj.onc.1206039 · Cited by 396
Self-citationChecking out the G2/M transition
Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 355
Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T. J., & Hung, M.-C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80157-4 · Cited by 353
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
Stewart, S. A., Poon, B., Jowett, J. B., & Chen, I. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5579-5592.1997 · Cited by 350
Oberhammer, F. A., Hochegger, K., Fröschl, G., Tiefenbacher, R., & Pavelka, M. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.4.827 · Cited by 341
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage
Jin, P., Hardy, S., & Morgan, D. O. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.875 · Cited by 298
Cdc2 Phosphorylation of BAD Links the Cell Cycle to the Cell Death Machinery
Konishi, Y., Lehtinen, M., Donovan, N., & Bonni, A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00524-5 · Cited by 287
Jacotot, E., Ferri, K. F., El Hamel, C., Brenner, C., Druillennec, S., Hoebeke, J., Rustin, P., Métivier, D., Lenoir, C., Geuskens, M., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.509 · Cited by 273
Self-citationHirose, Y., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 262
Ruchaud, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1967 · Cited by 260
Patel, V, Senderowicz, A. M., Pinto, D., Igishi, T., Raffeld, M., Quintanilla-Martinez, L., Ensley, J. F., Sausville, E. A., & Gutkind, J. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3661 · Cited by 246
Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases
Meikrantz, W., & Schlegel, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10205 · Cited by 234
Mammalian Target of Rapamycin (mTOR): Pro- and Anti-Apoptotic
Castedo, M., Ferri, K. F., & Kroemer, G. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400978 · Cited by 230
Self-citationScatena, C. D., Stewart, Z. A., Mays, D., Tang, L. J., Keefer, C. J., Leach, S. D., & Pietenpol, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30777 · Cited by 229
Apoptosis Control in Syncytia Induced by the HIV Type 1–Envelope Glycoprotein Complex
Ferri, K. F., Jacotot, E., Blanco, J., Esté, J. A., Zamzami, N., Susin, S. A., Xie, Z., Brothers, G., Reed, J. C., Penninger, J. M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1081 · Cited by 222
Self-citationLock, R. B., & Stribinskiene, L. (1996) · PubMed · Cited by 202
Mechanisms of G2 Arrest in Response to Overexpression of p53
Taylor, W. R., DePrimo, S. E., Agarwal, A., Agarwal, M. L., Schönthal, A. H., Katula, K. S., & Stark, G. R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3607 · Cited by 195
Chang, B.-D., Broude, E. V., Fang, J., Kalinichenko, T. V., Abdryashitov, R., Poole, J. C., & Roninson, I. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203573 · Cited by 168
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
Castedo, M., Roumier, T., Blanco, J., Ferri, K. F., Barretina, J., Tintignac, L. A. J., Andréau, K., Perfettini, J., Amendola, A., Nardacci, R., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf391 · Cited by 165
Self-citationItzhaki, J. E., Gilbert, C., & Porter, A. (1997) · Nature Genetics · doi:10.1038/ng0397-258 · Cited by 163
p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor
Yun, J., Chae, H.-D., Choy, H. E., Chung, J., Yoo, H.-S., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 159
Zhou, B.-B., Li, H., Yuan, J., & Kirschner, M. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6785 · Cited by 156
Castedo, M., Ferri, K. F., Blanco, J., Roumier, T., Larochette, N., Barretina, J., Amendola, A., Nardacci, R., Métivier, D., Este, J. A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1097 · Cited by 146
Self-citationAbundance of cyclin B1 regulates γ-radiation–induced apoptosis
Porter, L. A., Singh, G., & Lee, J. M. (2000) · Blood · doi:10.1182/blood.v95.8.2645 · Cited by 144
Tan, M., Jing, T., Lan, K., Neal, C. L., Li, P., Lee, S., Fang, D., Nagata, Y., Liu, J., Arlinghaus, R. B., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00510-5 · Cited by 128
HIV induces lymphocyte apoptosis by a p53‐initiated, mitochondrial‐mediated mechanism
Genini, D., Sheeter, D. A., Rought, S. E., Zaunders, J., Susín, S. A., Kroemer, G., Richman, D. D., Carson, D. A., Corbeil, J., & Leoni, L. M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0336fje · Cited by 127
Self-citationStewart, Z. A., Mays, D. J., & Pietenpol, J. A. (1999) · PubMed · Cited by 121
Curman, D., Cinel, B., Williams, D. E., Rundle, N., Block, W. D., Goodarzi, A. A., Hutchins, J. R., Clarke, P. R., Zhou, B.-B., Lees-Miller, S. P., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100728200 · Cited by 121
Activation-Induced T-Cell Death Is Cell Cycle Dependent and Regulated by Cyclin B
Fotedar, R., Flatt, J., Gupta, S., Margolis, R. L., Fitzgerald, P., Messier, H., & Fotedar, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.932 · Cited by 120
Vantieghem, A., Xu, Y., Assefa, Z., Piette, J., Vandenheede, J. R., Merlevede, W., de Witte, P. A. M., & Agostinis, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204348200 · Cited by 119
Wang, B., Ge, Y. C., Palasanthiran, P., Xiang, S.-H., Ziegler, J. B., Dwyer, D. E., Randle, C., Dowton, D., Cunningham, A. L., & Saksena, N. K. (1996) · Virology · doi:10.1006/viro.1996.0471 · Cited by 117
Roumier, T., Vieira, H. L. A., Castedo, M., Ferri, K. F., Boya, P., Andréau, K., Druillennec, S., Joza, N. A., Penninger, J. M., Roques, B. P., et al. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401089 · Cited by 100
Self-citationEvidence for a cytopathogenicity determinant in HIV-1 Vpr
Somasundaran, M., Sharkey, M., Brichacek, B., Luzuriaga, K., Emerman, M., Sullivan, J. L., & Stevenson, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142313699 · Cited by 100
Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1
Pathan, N., Aimé, C., Kitada, S., Haldar, S., & Reed, J. C. (2001) · Neoplasia · doi:10.1038/sj.neo.7900131 · Cited by 97
Shen, S., Huang, T., Jee, S., & Kuo, M. L. (1998) · PubMed · Cited by 87
Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage
Ongkeko, W., Ferguson, D. J. P., Harris, A. L., & Norbury, C. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.8.2897 · Cited by 83
Zhang, L., Huang, Y., Yuan, H. E., Tuttleton, S., & Ho, D. D. (1997) · Virology · doi:10.1006/viro.1996.8378 · Cited by 74
Ibrado, A. M., Kim, C. N., & Bhalla, K. N. (1998) · Leukemia · doi:10.1038/sj.leu.2401218 · Cited by 70
Vincent, I. J., Bu, B., Hudson, K., Husseman, J. W., Nochlin, D., & Jin, L.-W. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00219-6 · Cited by 63
CDC2 Activation Is Not Required for Thymocyte Apoptosis
Norbury, C. J., MacFarlane, M., Fearnhead, H. O., & Cohen, G. M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2086 · Cited by 62
Yao, S.-L., Mckenna, K. A., Sharkis, S. J., & Bedi, A. (1996) · PubMed · Cited by 56
The Radioresistance to Killing of A1–5 Cells Derives from Activation of the Chk1 Pathway
Hu, B., Zhou, X.-Y., Wang, X., Zeng, Z.-C., Iliakis, G., & Wang, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009340200 · Cited by 49
Apoptosis and karyogamy in syncytia induced by the HIV-1-envelope glycoprotein complex
Ferri, K. F., Jacotot, E. D., Geuskens, M., & Kroemer, G. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400748 · Cited by 46
Self-citationHuman immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death.
Kolesnitchenko, V., Wahl, L. M., Tian, H., Sunila, I., Tani, Y., Hartmann, D. P., Cossman, J., Raffeld, M. A., Orenstein, J. M., & Samelson, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11889 · Cited by 42
Nishizawa, M., Kamata, M., Katsumata, R., & Aida, Y. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6058-6067.2000 · Cited by 42
Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients
Piedimonte, G., Corsi, D., Paiardini, M., Cannavò, G., Ientile, R., Picerno, I., Montroni, M., Silvestri, G., & Magnani, M. (1999) · AIDS · doi:10.1097/00002030-199907090-00003 · Cited by 35
Paiardini, M., Galati, D., Cervasi, B., Cannavò, G., Galluzzi, L., Montroni, M., Guétard, D., Magnani, M., Piedimonte, G., & Silvestri, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10843-10855.2001 · Cited by 31
Uncoupling of M-phase kinase activation from the completion of S-phase by heat shock.
Mackey, M. A., Zhang, X. F., Hunt, C. R., Sullivan, S. J., BLUM, J. J., Laszlo, A., & Roti, J. L. R. (1996) · PubMed · Cited by 21
Castedo, M., & Kroemer, G. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02346-2 · Cited by 13
Self-citation
Research works printed but not linked: 1
- Zhai S, Senderowicz AM, Sausville EA, Figg WD . 2002 Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development Ann. Pharmacother. 36: 905–911 · doi:10.1345/aph.1a162 · Paper page
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
“, a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
BackgroundSelf-citationCell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269
“…or genetic manipulations, for instance, in human colorectal adenocarcinoma cell lines treated with fluorouracil (Yoshikawa et al., 2001), 14-3-3s / colon cancer cells treated with doxorubicin (Chan et al., 1999), as well as in heterokarya induced by cell fusion (Castedo et al., 2001, 2002b).”
BackgroundSelf-citationPathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
YAP/TAZ Signaling and Resistance to Cancer Therapy
Nguyen, C. D. K., & Yi, C. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.02.010 · Cited by 437
“Conversely, Cyclin-dependent kinase 1 (CDK1), sensitizes ovarian cancer cells to taxanes by phosphorylating LATS1/2 and YAP/TAZ [75,78,80,84,86,87].”
BackgroundTrial watch: IDO inhibitors in cancer therapy
Vacchelli, E., Aranda, F., Eggermont, A., Sautès-Fridman, C., Tartour, E., Kennedy, E. P., Platten, M., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014) · OncoImmunology · doi:10.4161/21624011.2014.957994 · Cited by 326
Self-citation
Metadata
- Authors
- Castedo, M., Perfettini, J.-L., Roumier, T., & Kroemer, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Kroemer, G
- Venue
- Cell Death & Differentiation
- Published
- 2002-12
- Volume
- 9
- Issue
- 12
- Pages
- 1287-1293
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2084337297
- Cited by
- 345
- References
- 66
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 18 · 2020: 11 · 2019: 15 · 2018: 24 · 2017: 17 · 2016: 14 · 2015: 12 · 2014: 23 · 2013: 13 · 2012: 14
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sidaction
- European Commission
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cyclin-dependent kinase 1, CDK1, apoptosis, mitotic catastrophe, cell cycle regulation, cyclin B1, CDK1 activation, breast cancer, ERBB2, p53, mitochondrial membrane permeabilization, neuronal apoptosis, neurodegenerative diseases, CDK1 inhibition
- MeSH terms
- Animals, DNA Damage, Eukaryotic Cells, Humans, Mitosis, HIV-1, CDC2 Protein Kinase, Apoptosis, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.